Skip to main content
OpenTrials
Completed

NCT Number: NCT03469739

Types of Intimate Partner Violence and Women's Health

This study uses data from 29,990 women from 12 different countries collected by the WHO multi-country study on women's health and domestic violence to capture the effect of different types, frequency and timing of IPV on self-reported health, symptoms and suicidal behaviours.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Domestic Violence

Age range

15 year–49 year

Sex eligibility

Female

Study type

Observational

About this study

Intimate partner violence (IPV) has detrimental effects on physical and mental health, risks to children and is associated with wider societal and healthcare costs. Previous analysis of the WHO multi-country study on women's health and domestic violence found significant associations between physical and sexual IPV and self-reported ill-health, symptomatology and suicidal behaviours.

Real experience of IPV can comprise different combinations of emotional, physical and sexual abuse, and different timings and frequencies of these. A more nuanced testing of exposure to these different combinations of IPV and associations with health is needed.

This study uses data from 29,990 women from 12 different countries collected by the WHO multi-country study on women's health and domestic violence to capture the effect of different combination types, frequency and timing of IPV on self-reported health, symptoms and suicidal behaviours.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The WHO report that in most sites, a representative sample of women was obtained using a two-stage cluster sampling scheme to select households and then only one woman per household was randomly selected per household for interview.

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. Participant description of their current overall state of health

    Time frame: Preceding 4 weeks

    Participant description of their current overall state of health- a choice of options- excellent, good, fair, poor or very poor.

Secondary outcomes

  1. Participant reported health in the last 4 weeks- problems walking around, doing usual activities, pain or discomfort, problems with memory or concentration, dizziness or vaginal discharge. Measured by questionnaire.

    Time frame: Preceding 4 weeks

    Participant rating of various health aspects in last 4 weeks

  2. Emotional distress. Measured by questionnaire of 20 different symptoms of emotional distress. SRQ-20 (score of 20 different symptoms of emotional distress with yes/no answers)

    Time frame: Preceding 4 weeks

    Self Reporting Questionnaire-20 (SRQ-20)- aggregate score of 20 different symptoms of emotional distress with yes/no answers

  3. Participant reported ever suicidal thoughts or attempts; measured by questionnaire.

    Time frame: Up to 49 years

    Participants reporting ever having suicidal thoughts or ever attempting suicide

  4. Participant reported medication used for sleep/ pain; measured by questionnaire.

    Time frame: Preceding 4 weeks

    Participants reporting medication use

Sponsors and collaborators

Lead sponsor

University of Bristol

Other

Registry information

Official study title

Types of Intimate Partner Violence and Women's Health: Findings From the WHO Multi-country Study on Women's Health and Intimate Partner Violence

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Mar 19, 2018
Registry last updated
Mar 19, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.